AMPLATZER™ Amulet™ LAA Occluder Trial

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 1878 participants.

Also called NCT02879448

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose prevention
Phase
Not applicable
Enrolled
  • 1,878 participants (enrolled count) (from the registry)
Sponsor
  • Abbott Registry lists this organization as the lead sponsor
Registry
  • NCT NCT02879448
Other papers using this trial's data
  • 3-Year Outcomes From the Amplatzer Amulet Left Atrial Appendage Occluder Randomized Controlled Trial (Amulet IDE) JACC. Cardiovascular interventions, 2023-08-14 DOI, PubMed 37587599
  • 5-Year Results From the AMPLATZER Amulet Left Atrial Appendage Occluder Randomized Controlled Trial Journal of the American College of Cardiology, 2025-03-25 DOI, PubMed 39570242
  • Amplatzer Amulet Left Atrial Appendage Occluder Versus Watchman Device for Stroke Prophylaxis (Amulet IDE): A Randomized, Controlled Trial Circulation, 2021-11-09 DOI, PubMed 34459659, PMC8570346 In the PMC Open Access subset under CC BY-NC-ND.
  • Characterization and Clinical Outcomes of High-Risk Device-Related Thrombus in the Amulet IDE Trial JACC. Clinical electrophysiology, 2025-07 DOI, PubMed 40208159
  • Incidence, Predictors, Management, and Clinical Impact of Major Bleeding Following Left Atrial Appendage Occlusion: The Amulet IDE Randomized Clinical Trial JAMA cardiology, 2026-05-01 DOI, PubMed 41879767, PMC13019334 Not in the PMC Open Access subset.
  • Mechanisms, predictors, and evolution of severe peri-device leaks with two different left atrial appendage occluders Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 2023-08-02 DOI, PubMed 37584233, PMC10427960 In the PMC Open Access subset under CC BY-NC.
  • Peridevice Leak After Transcatheter Left Atrial Appendage Occlusion: An Analysis of the Amulet IDE Trial JACC. Cardiovascular interventions, 2022-11-14 DOI, PubMed 36357016

Courtesy of the U.S. National Library of Medicine.

Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States, Australia, Canada, Czechia, Denmark, Germany, Italy, Netherlands, Portugal, Spain, Switzerland (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT02879448. Randomized; no masking; primary purpose prevention. Start 2016-08-24 (registry gives no type); primary completion 2020-12-07 (actual). Results posted on 2022-01-11.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
AMPLATZER™ Amulet™ LAA Occluder Trial
Acronym
Amulet IDE
Condition
Stroke
Intervention (Device)
Amulet Left Atrial Appendage Occluder
Intervention (Device)
WATCHMAN Left Atrial Appendage Closure
Lead sponsor
Abbott Medical Devices (class: industry)

Record details

Record id
cardio:ct-nct02879448
Content hash
251ead3db4e26294db601810625d0b6adb9e6d4e67f5fe51ca5d9d72f507b3bf